Provided by Tiger Fintech (Singapore) Pte. Ltd.

CINGULATE INC.

4.35
-0.0800-1.81%
Post-market: 4.350.00000.00%19:40 EDT
Volume:81.49K
Turnover:354.17K
Market Cap:18.47M
PE:-0.62
High:4.43
Open:4.36
Low:4.25
Close:4.43
Loading ...

Cingulate Inc. Files Initial Statement of Beneficial Ownership for Nilay Patel, CLO & CCO

Reuters
·
11 Jul

Cingulate appoints Nilay Patel as Chief Legal Officer

TIPRANKS
·
09 Jul

Cingulate Appoints Nilay Patel as Chief Legal Officer to Support Growth ahead of New Drug Application

GlobeNewswire
·
09 Jul

H.C. Wainwright Remains a Buy on Cingulate Inc (CING)

TIPRANKS
·
01 Jul

Stonegate Capital Partners Initiates Coverage on Cingulate Inc.'s Progress Towards ADHD Treatment Launch

Reuters
·
18 Jun

Cingulate Inc Approves Key Proposals at Annual Meeting

TIPRANKS
·
11 Jun

Cingulate Inc. Conducted Annual Stockholders Meeting

Reuters
·
11 Jun

Cingulate Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
27 May

Roth MKM Sticks to Their Buy Rating for Cingulate Inc (CING)

TIPRANKS
·
23 May

Cingulate announces efficacy results from Phase 3 study of CTx-1301

TIPRANKS
·
20 May

Efficacy Results Announced From Cingulate’s Phase 3 Pediatric Study of Ctx-1301 (Dexmethylphenidate) for Adhd

THOMSON REUTERS
·
20 May

Efficacy Results Announced from Cingulate’s Phase 3 Pediatric Study of CTx-1301 (dexmethylphenidate) for ADHD

GlobeNewswire
·
20 May

Cingulate Is Maintained at Buy by Roth Capital

Dow Jones
·
20 May

Analysts Conflicted on These Healthcare Names: Axsome Therapeutics (AXSM), Waters (WAT) and Cingulate Inc (CING)

TIPRANKS
·
19 May

Cingulate price target lowered to $11 from $12 at Roth Capital

TIPRANKS
·
19 May

FDA and Cingulate Aligned With Filing Requirements for New Drug Application for Lead Adhd Asset Ctx-1301

THOMSON REUTERS
·
14 May

Cingulate Inc - Plans Nda Submission for Ctx-1301 This Summer

THOMSON REUTERS
·
14 May

Cingulate Inc: Pre-Nda Meeting With FDA Is Aligned With Plans to Submit a Nda for Ctx-1301 This Summer

THOMSON REUTERS
·
14 May

Cingulate Inc Terminates Grant Agreement with Foundation

TIPRANKS
·
14 May

Cingulate Q1 EPS $(1.04) Misses $(0.92) Estimate

Benzinga
·
09 May